These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 20738752

  • 1. TP53 mutations in clinically normal mucosa adjacent to oral carcinomas.
    Thode C, Bilde A, Von Buchwald C, Dabelsteen E.
    J Oral Pathol Med; 2010 Oct; 39(9):662-6. PubMed ID: 20738752
    [Abstract] [Full Text] [Related]

  • 2. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
    Scheifele C, Schlechte H, Bethke G, Reichart PA.
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
    [Abstract] [Full Text] [Related]

  • 3. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM, Björnsson J, Holbrook WP.
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. P53-mutation in smears of oral squamous cell carcinoma.
    Friedrich RE, Giese M, Riethdorf S, Loning T.
    Anticancer Res; 2000 Aug; 20(6D):4927-30. PubMed ID: 11326641
    [Abstract] [Full Text] [Related]

  • 7. [P53 expression and clinical significance in oral squamous cell carcinoma].
    Long Y, Ling D, Yue W.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
    [Abstract] [Full Text] [Related]

  • 8. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
    Fukuda M, Nakatsuka T, Kusama K, Sakashita H.
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
    Cruz IB, Meijer CJ, Snijders PJ, Snow GB, Walboomers JM, van Der Waal I.
    J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF, Labib El-Sharkawy S, Abbas EA, Abdel Monem El-Shaer M.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
    Ebrahimi M, Wahlin YB, Coates PJ, Sjöström B, Nylander K.
    J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
    [Abstract] [Full Text] [Related]

  • 13. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK, Hsue SS, Lin LM.
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [Abstract] [Full Text] [Related]

  • 14. [Detection of p53 mutation in mouth mucosa smears of patients with oral squamous epithelial carcinoma].
    Giese M, Friedrich RE, Riethdorf S, Löning T.
    Mund Kiefer Gesichtschir; 2001 Jan; 5(1):37-43. PubMed ID: 11272386
    [Abstract] [Full Text] [Related]

  • 15. p53 gene alterations and p53 protein in oral epithelial dysplasia and squamous cell carcinoma.
    Kusama K, Okutsu S, Takeda A, Himiya T, Kojima A, Kidokoro Y, Chu L, Iwanari S, Kudo I, Moro I.
    J Pathol; 1996 Apr; 178(4):415-21. PubMed ID: 8691320
    [Abstract] [Full Text] [Related]

  • 16. Expression of inducible nitric oxide synthase and p53 in oral epithelial dysplasia.
    Brennan PA, Conroy B, Spedding AV.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):624-9. PubMed ID: 11077387
    [Abstract] [Full Text] [Related]

  • 17. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.
    Perrone F, Bossi P, Cortelazzi B, Locati L, Quattrone P, Pierotti MA, Pilotti S, Licitra L.
    J Clin Oncol; 2010 Feb 10; 28(5):761-6. PubMed ID: 20048189
    [Abstract] [Full Text] [Related]

  • 18. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
    Kashiwazaki H, Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, Iggo R, Moriuchi T.
    Oncogene; 1997 Nov 27; 15(22):2667-74. PubMed ID: 9400993
    [Abstract] [Full Text] [Related]

  • 19. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
    Ries JC, Schreiner D, Steininger H, Girod SC.
    Anticancer Res; 1998 Nov 27; 18(3B):2031-6. PubMed ID: 9677462
    [Abstract] [Full Text] [Related]

  • 20. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.
    Head Neck; 2009 Aug 27; 31(8):1039-48. PubMed ID: 19340865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.